Shuttle Pharmaceuticals Reports Q2 2023 Net Loss of $2.18 Million

Shuttle Pharmaceuticals Holdings, Inc.(SHPH), a leading pharmaceutical company, has releas ed its unaudited condensed consolidated financial statements for the second quarter of 2023, revealing a net loss of $2.18 million. The company also reported zero revenue for the quarter, continuing its trend of focusing on research and development activities.

Net Loss Widens in Q2 2023

Shuttle Pharmaceuticals experienced a net loss of $2.18 million for the second quarter of 2023, marking an increase from the net loss of $597,275 reported during the same period in 2022. This widening net loss can be attributed to various factors, including increased operating expenses and interest expenses.

Lack of Revenue Persists